Incidence and risk factors of new clinical disorders in patients with COVID-19 hyperinflammatory syndrome
Abstract This study investigated new incident clinical disorders in patients with COVID-19-related hyperinflammatory syndrome (cHIS) 3.5 years post infection. We analyzed 14,335 patients hospitalized with COVID-19 from March-2020 to July-2023. cHIS was defined based on a point system that included e...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-06-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-04070-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850223947893702656 |
|---|---|
| author | Kevin E. Duong Justin Y. Lu Stephen Wang Tim Q. Duong |
| author_facet | Kevin E. Duong Justin Y. Lu Stephen Wang Tim Q. Duong |
| author_sort | Kevin E. Duong |
| collection | DOAJ |
| description | Abstract This study investigated new incident clinical disorders in patients with COVID-19-related hyperinflammatory syndrome (cHIS) 3.5 years post infection. We analyzed 14,335 patients hospitalized with COVID-19 from March-2020 to July-2023. cHIS was defined based on a point system that included elevated body temperature, macrophage activation, hematological dysfunction, coagulopathy, and hepatic enzyme. Outcomes were newly diagnosed disorders of hypertension, diabetes, cardiovascular diseases, chronic kidney disease (CKD), chronic obstructive pulmonary disease (COPD), and asthma post COVID-19. Cumulative incidences and hazard ratios were computed. Compared to non-cHIS patients, cHIS patients were older, fewer female, more Blacks, higher prevalence of pre-existing comorbidities. Patients with cHIS had higher risk of developing cardiovascular disease (HR = 1.24 [1.04,1.47] p < 0.05), CKD (1.24 [1.01, 1.53] p < 0.05), and obesity (1.61 [1.31,1.98], p < 0.001) but not hypertension, diabetes, COPD, and asthma. Cumulative incidence analysis showed that patients ≥ 50 years old showed markedly higher new incidences of individual new disorders compared to patients < 50 years old. COVID-19 related hyperinflammatory syndrome confers a significantly higher risk for developing new common clinical disorders. Identifying risks for developing new clinical disorders in patients with COVID-19 related hyperinflammatory syndrome may encourage diligent follow-up of high-risk individuals. |
| format | Article |
| id | doaj-art-e42f7dbb72b84e259e84ba782b4d3544 |
| institution | OA Journals |
| issn | 2045-2322 |
| language | English |
| publishDate | 2025-06-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Scientific Reports |
| spelling | doaj-art-e42f7dbb72b84e259e84ba782b4d35442025-08-20T02:05:47ZengNature PortfolioScientific Reports2045-23222025-06-011511910.1038/s41598-025-04070-9Incidence and risk factors of new clinical disorders in patients with COVID-19 hyperinflammatory syndromeKevin E. Duong0Justin Y. Lu1Stephen Wang2Tim Q. Duong3Department of Radiology, Albert Einstein College of Medicine and Montefiore Medical CenterDepartment of Radiology, Albert Einstein College of Medicine and Montefiore Medical CenterDepartment of Radiology, Albert Einstein College of Medicine and Montefiore Medical CenterDepartment of Radiology, Albert Einstein College of Medicine and Montefiore Medical CenterAbstract This study investigated new incident clinical disorders in patients with COVID-19-related hyperinflammatory syndrome (cHIS) 3.5 years post infection. We analyzed 14,335 patients hospitalized with COVID-19 from March-2020 to July-2023. cHIS was defined based on a point system that included elevated body temperature, macrophage activation, hematological dysfunction, coagulopathy, and hepatic enzyme. Outcomes were newly diagnosed disorders of hypertension, diabetes, cardiovascular diseases, chronic kidney disease (CKD), chronic obstructive pulmonary disease (COPD), and asthma post COVID-19. Cumulative incidences and hazard ratios were computed. Compared to non-cHIS patients, cHIS patients were older, fewer female, more Blacks, higher prevalence of pre-existing comorbidities. Patients with cHIS had higher risk of developing cardiovascular disease (HR = 1.24 [1.04,1.47] p < 0.05), CKD (1.24 [1.01, 1.53] p < 0.05), and obesity (1.61 [1.31,1.98], p < 0.001) but not hypertension, diabetes, COPD, and asthma. Cumulative incidence analysis showed that patients ≥ 50 years old showed markedly higher new incidences of individual new disorders compared to patients < 50 years old. COVID-19 related hyperinflammatory syndrome confers a significantly higher risk for developing new common clinical disorders. Identifying risks for developing new clinical disorders in patients with COVID-19 related hyperinflammatory syndrome may encourage diligent follow-up of high-risk individuals.https://doi.org/10.1038/s41598-025-04070-9Long COVIDPost-acute sequela of SARS-CoV-2 infection (PASC)Cytokine storm |
| spellingShingle | Kevin E. Duong Justin Y. Lu Stephen Wang Tim Q. Duong Incidence and risk factors of new clinical disorders in patients with COVID-19 hyperinflammatory syndrome Scientific Reports Long COVID Post-acute sequela of SARS-CoV-2 infection (PASC) Cytokine storm |
| title | Incidence and risk factors of new clinical disorders in patients with COVID-19 hyperinflammatory syndrome |
| title_full | Incidence and risk factors of new clinical disorders in patients with COVID-19 hyperinflammatory syndrome |
| title_fullStr | Incidence and risk factors of new clinical disorders in patients with COVID-19 hyperinflammatory syndrome |
| title_full_unstemmed | Incidence and risk factors of new clinical disorders in patients with COVID-19 hyperinflammatory syndrome |
| title_short | Incidence and risk factors of new clinical disorders in patients with COVID-19 hyperinflammatory syndrome |
| title_sort | incidence and risk factors of new clinical disorders in patients with covid 19 hyperinflammatory syndrome |
| topic | Long COVID Post-acute sequela of SARS-CoV-2 infection (PASC) Cytokine storm |
| url | https://doi.org/10.1038/s41598-025-04070-9 |
| work_keys_str_mv | AT kevineduong incidenceandriskfactorsofnewclinicaldisordersinpatientswithcovid19hyperinflammatorysyndrome AT justinylu incidenceandriskfactorsofnewclinicaldisordersinpatientswithcovid19hyperinflammatorysyndrome AT stephenwang incidenceandriskfactorsofnewclinicaldisordersinpatientswithcovid19hyperinflammatorysyndrome AT timqduong incidenceandriskfactorsofnewclinicaldisordersinpatientswithcovid19hyperinflammatorysyndrome |